Skip to main content
. 2018 Sep 21;24(35):4036–4053. doi: 10.3748/wjg.v24.i35.4036

Figure 6.

Figure 6

Daikenchuto upregulates transient receptor potential ankyrin 1 expression and suppresses phosphorylation events downstream of transforming growth factor-β1 signaling. A: trpa1 mRNA expression quantified by real-time PCR in control and TGF-β1-treated (5 ng/mL, 24 h) InMyoFibs (normalized to 18S rRNA). DKT extracts (0.001%, 0.01%, 0.1%) were applied for 24 h; B: Relative mRNA expression of trpa1 with ginger (0.1%), ginseng radix (0.1%), Japanese pepper (0.1%), or DKT (0.1%) plus co-administered TGF-β1; C: trpa1 mRNA expression was upregulated by TGF-β1, TNF-α, or both; D: TRPA1 protein expression and phosphorylation of Smad-2 or p38-MAPK with and without TGF-β1 treatment at various concentrations of DKT extracts (0.001%, 0.01%, and 0.1%). The upper panel shows actual immunoblots. Graphs show relative expression level of TRPA1 (normalized to β-actin) and the relative ratios of phosphorylated/unphosphorylated Smad-2 and p38-MAPK (normalized to β-actin) after 1 h TGF-β1 treatment at various DKT concentrations. aP < 0.05 vs control cells, bP < 0.05 vs TGF-β1-treated cells (n = 4). TGF-β1: Transforming growth factor-β1; InMyoFibs: Intestinal myofibroblasts; DKT: Daikenchuto; TRPA1: Transient receptor potential ankyrin 1; p38-MAPK: p38-mitogen-activated protein kinase.